Terms: = Gastric cancer AND BCR, FLJ16453, 613, ENSG00000186716, BCR1, D22S662, D22S11, CML, P11274, PHL, ALL AND Clinical Outcome
4 results:
1. Treatment of Metastatic or High-Risk Solid cancer Patients by Targeting the Immune System and/or Tumor Burden: Six Cases Reports.
Nicolini A; Ferrari P; Morganti R; Carpi A
Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31795079
[TBL] [Abstract] [Full Text] [Related]
2. Neo-adjuvant Chemotherapy-Induced Neutropenia Is Associated with Histological Responses and outcomes after the Resection of Colorectal Liver Metastases.
Chen Q; Wu C; Zhao H; Wu J; Zhao J; Bi X; Li Z; Huang Z; Zhang Y; Zhou J; Cai J
J Gastrointest Surg; 2020 Mar; 24(3):659-670. PubMed ID: 30937711
[TBL] [Abstract] [Full Text] [Related]
3. cancerous inhibitor of PP2A (CIP2A) at diagnosis of chronic myeloid leukemia is a critical determinant of disease progression.
Lucas CM; Harris RJ; Giannoudis A; Copland M; Slupsky JR; Clark RE
Blood; 2011 Jun; 117(24):6660-8. PubMed ID: 21490338
[TBL] [Abstract] [Full Text] [Related]
4. Distinct gene expression-defined classes of gastrointestinal stromal tumor.
Yamaguchi U; Nakayama R; Honda K; Ichikawa H; Hasegawa T; Shitashige M; Ono M; Shoji A; Sakuma T; Kuwabara H; Shimada Y; Sasako M; Shimoda T; Kawai A; Hirohashi S; Yamada T
J Clin Oncol; 2008 Sep; 26(25):4100-8. PubMed ID: 18757323
[TBL] [Abstract] [Full Text] [Related]